MyAverix Finance
NS · Pharmaceuticals
Zim Laboratories Ltd (ZIMLAB)
Pharmaceuticals & Biotechnology
Zim Laboratories Ltd (ZIMLAB) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $6.47B, P/E ratio is 109.01, net margin is 3.1%, dividend yield is 0.41%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ZIMLAB
Zim Laboratories Ltd (ZIMLAB) — FAQ
What is Zim Laboratories Ltd's market cap?
Zim Laboratories Ltd (ZIMLAB) has a reported market cap of $6.47B (data as of 2026-07-10).
What is ZIMLAB's P/E ratio?
The price-to-earnings (P/E) ratio for Zim Laboratories Ltd (ZIMLAB) is 109.01 (data as of 2026-07-10).
Does Zim Laboratories Ltd pay a dividend?
Zim Laboratories Ltd (ZIMLAB) shows a reported dividend yield of 0.41%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Zim Laboratories Ltd in?
Zim Laboratories Ltd (ZIMLAB) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is ZIMLAB listed on?
ZIMLAB is listed on NS.
What is Zim Laboratories Ltd's net margin?
Zim Laboratories Ltd (ZIMLAB) reports a net margin of 3.1% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.